cbdMD approves 1-for-45 reverse stock split effective April 24, 2023

cbdMD, Inc.

Reverse split reduces outstanding shares from ~65.5M to ~1.45M; fractional shares rounded up.
Split intended to meet NYSE American minimum price listing standard.
Common stock continues trading under YCBD; new CUSIP 12482W 309.
Proportionate adjustments to options, warrants, and Series A preferred conversion.
Effective after market close April 24; trading on split-adjusted basis April 25.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.